Cantata Health Unveils Key Additions to EHR Software for Long-term Care Providers
AUSTIN, Texas, Dec. 13, 2018 Cantata Health, a leading provider of software and services that improves patient visibility, operational efficiency and financial outcomes, introduced new enhancements to its NetSolutionstm platform. The new features and partnerships allow LTC providers to focus on quality care and financial leadership, rather than technology and screen time.
Enhancements made to EHR and Financial Management modules on the NetSolutions Long-Term Care (LTC) Platform include:
Out-of-the-box Content: Makes staff more efficient with pre-configured content based on the most current clinical evidence and best practices. Ready-to-use assessments, documentation templates, order sets, and more are available and can be tailored to each facility's unique workflows and process for enhanced flexibility, greater visibility to patient care and more efficient revenue recovery.
Secure and Direct Messaging: Enables Skilled Nursing Facilities and Assisted Living Communities to send and receive HIPAA-compliant electronic communication for a smoother transition of care between providers. More efficient than faxing, there is also no loss of quality during transmission, and confirmation of delivery is always included.?
Real-time Connections: Exchange information seamlessly through a bi-directional connection from the NetSolutions EHR platform to third-party providers. The data is fully synchronized and available real-time, ensuring that clinicians are working with the most current patient information and data.
Unified Partner Experience: Cantata added WoundRounds and ABILITY to their network of healthcare partners focused on providing a seamless continuum of care and greater visibility to patient needs. Clients benefit from the single-sign-on and data integration capabilities, creating efficiencies at the point of care and improved billing management and revenue recovery.
"We continue to drive enhancements to NetSolutions that provide visibility to all aspects of the patient care continuum while ensuring the financial health of the facility," said Les Wilson, Sr. Director of Product Management for Cantata Health. "The new features and functionality will help facility administration and staff make more informed decisions on patient care and back-office operations."
Cantata Health delivers award-winning Revenue Cycle Management (RCM) and Electronic Health Records (EHR) software for acute, post-acute and long-term care (LTC) facilities purpose-built for the unique needs of each facility or system. Cantata's configurable solutions provide leaders greater visibility to patient care across the continuum of care and predictable financial outcomes: improving back-office operations, clinical efficiency, and revenue recovery. Headquartered in Austin, Texas, our team of experts provide uncommonly attentive service and support focused on improving key quality outcomes.
Medtronic plc , a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptivtm closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv...
The "KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive insights about KEYTRUDA for ovarian cancer in the seven major markets. A detailed...
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030
The global market for Laboratory...
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...